Lataa...
Drug Licenses: A Better Model for Pharmaceutical Pricing
High drug prices are a substantial barrier to patient access and compliance. Yet, low drug prices are often argued to provide inadequate incentives for innovation. We propose a “drug-licensing” model for health care which has the promise of increasing drug utilization without altering patient out-of...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3756826/ https://ncbi.nlm.nih.gov/pubmed/18180487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1377/hlthaff.27.1.122 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|